IRIS
ALDRIGHETTI, LUCA ANTONIO MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 21.155
EU - Europa 18.539
NA - Nord America 14.803
SA - Sud America 5.926
AF - Africa 492
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 25
AN - Antartide 1
Totale 60.972
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.997
RU - Federazione Russa 10.859
SG - Singapore 8.096
CN - Cina 5.613
BR - Brasile 4.833
HK - Hong Kong 2.711
VN - Vietnam 2.142
IT - Italia 2.112
SE - Svezia 1.573
FR - Francia 1.008
BD - Bangladesh 930
DE - Germania 755
AR - Argentina 404
FI - Finlandia 397
GB - Regno Unito 358
CA - Canada 354
IN - India 342
IE - Irlanda 303
RO - Romania 288
MX - Messico 229
AT - Austria 225
EC - Ecuador 225
ID - Indonesia 202
IQ - Iraq 163
ZA - Sudafrica 149
NL - Olanda 146
JP - Giappone 141
PL - Polonia 120
CO - Colombia 114
ES - Italia 109
TR - Turchia 101
PY - Paraguay 94
MA - Marocco 88
VE - Venezuela 88
PK - Pakistan 86
UA - Ucraina 74
CL - Cile 73
UZ - Uzbekistan 71
MY - Malesia 70
SA - Arabia Saudita 61
EG - Egitto 53
KE - Kenya 50
NP - Nepal 47
TN - Tunisia 44
LT - Lituania 43
JM - Giamaica 42
PE - Perù 42
AE - Emirati Arabi Uniti 41
PH - Filippine 36
AZ - Azerbaigian 32
DZ - Algeria 32
UY - Uruguay 32
HN - Honduras 31
AU - Australia 26
JO - Giordania 26
DO - Repubblica Dominicana 25
KR - Corea 25
CR - Costa Rica 24
KZ - Kazakistan 24
CH - Svizzera 23
IL - Israele 22
IR - Iran 21
OM - Oman 20
TT - Trinidad e Tobago 19
GT - Guatemala 18
NI - Nicaragua 18
BE - Belgio 17
TH - Thailandia 17
BH - Bahrain 16
LB - Libano 14
TW - Taiwan 14
AL - Albania 13
BO - Bolivia 13
BY - Bielorussia 13
PA - Panama 12
SK - Slovacchia (Repubblica Slovacca) 11
A1 - Anonimo 10
GR - Grecia 10
HU - Ungheria 10
ET - Etiopia 9
PS - Palestinian Territory 9
RS - Serbia 9
AO - Angola 8
BB - Barbados 8
CI - Costa d'Avorio 8
CZ - Repubblica Ceca 8
KG - Kirghizistan 8
NO - Norvegia 8
SY - Repubblica araba siriana 8
XK - ???statistics.table.value.countryCode.XK??? 8
BS - Bahamas 7
CG - Congo 7
LY - Libia 7
MD - Moldavia 7
SN - Senegal 7
SV - El Salvador 7
GE - Georgia 6
KH - Cambogia 6
KW - Kuwait 6
MK - Macedonia 6
Totale 60.847
Salva come PNG Salva come JPEG
Città #
Dallas 3.866
Singapore 3.721
Hong Kong 2.680
Moscow 2.360
San Jose 1.698
Ashburn 1.611
Shanghai 1.081
Hefei 986
Ho Chi Minh City 841
Lauterbourg 832
Lawrence 740
Princeton 740
Beijing 557
New York 472
Hanoi 434
Milan 419
São Paulo 356
Los Angeles 344
Helsinki 312
Santa Clara 302
Dublin 298
Rome 241
Nuremberg 234
Rio de Janeiro 152
Orem 133
Boardman 130
Munich 117
Da Nang 112
Vienna 110
Warsaw 104
Council Bluffs 102
Belo Horizonte 96
Tokyo 96
Brasília 94
Brooklyn 86
Montreal 85
Chicago 82
Frankfurt am Main 82
London 82
Atlanta 81
Mexico City 79
Curitiba 78
Guayaquil 78
Chennai 77
Quito 77
Guangzhou 76
Toronto 76
Houston 74
Johannesburg 73
Haiphong 72
Campinas 69
Denver 69
Naples 69
Stockholm 69
Tashkent 66
Baghdad 63
Porto Alegre 63
Buffalo 60
Biên Hòa 59
Bologna 57
Poplar 57
Boston 53
Guarulhos 50
Phoenix 50
Salvador 50
Mumbai 47
Cesano Boscone 46
Seattle 46
Amsterdam 45
Manchester 44
Lappeenranta 43
San Francisco 43
Jakarta 39
Nairobi 39
Turku 39
Buenos Aires 38
Dhaka 38
Santo André 38
Fortaleza 37
Kuala Lumpur 37
Memphis 37
Thái Bình 37
Hải Dương 36
Ribeirão Preto 36
Tianjin 36
Turin 36
Brescia 35
Goiânia 35
Shenzhen 35
Can Tho 34
Washington 34
Recife 33
Baku 32
Manaus 32
Omaha 32
Philadelphia 32
Florence 31
Miami 30
Asunción 29
Santiago 29
Totale 29.823
Salva come PNG Salva come JPEG
Nome #
111In-octreotide SPECT in occult carcinoid tumors 1.409
A prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts 324
In vivo macrophage engineering reshapes the tumor microenvironment leading to eradication of liver metastases 196
[Clinical value of spleen autograft]. FT Considerazioni sul valore clinico dell'autoinnesto di milza 189
Revealing and harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells 181
Recommendations for laparoscopic liver resection: A report from the second international consensus conference held in morioka 180
[Conservative treatment of postoperative pancreatic fistula. Role of interventional radiology]. FT Trattamento conservativo della fistola pancreatica postoperatoria. Ruolo della radiologia interventistica 178
. Il trapianto di isole pancreatiche come alternativa alla terapia sostitutiva insulinica intensiva nei pazienti affetti da diabete mellito di tipo 1: l'esperienza dell'Istituto Scientifico San Raffale di Milano 170
[Continuous 24-hour intragastric pH monitoring. A new model of interpretation]. FT La pHmetria endogastrica continua sulle 24 ore. Nuovo modello d'interpretazione 167
18 casi di incidentaloma della colecisti: analisi della casistica di un singolo centro 166
Endoscopic ultrasound-guided choledochoduodenostomy versus hepaticogastrostomy combined with gastroenterostomy in malignant double obstruction (CABRIOLET_Pro): A prospective comparative study 161
A comparison between robotic, laparoscopic and open hepatectomy: A systematic review and network meta-analysis 161
"Technological" approach versus clamp crushing technique for hepatic parenchymal transection: A comparative study 159
A machine learning predictive model for recurrence of resected distal cholangiocarcinoma: Development and validation of predictive model using artificial intelligence 157
Chromatin Velocity reveals epigenetic dynamics by single-cell profiling of heterochromatin and euchromatin 156
EUS-guided GastroEnterostomy for management of malignant Gastric Outlet Obstruction: a prospective cohort study with matched comparison with Enteral Stenting 155
[Intestinal occlusion in cocaine-packet ingestion]. FT L'occlusione intestinale nella cocaine-packet ingestion 155
A comprehensive preoperative predictive score for post-hepatectomy liver failure after hepatocellular carcinoma resection based on patient comorbidities, tumor burden, and liver function: the CTF score 154
A Composite Endpoint of Liver Surgery (CELS): Development and Validation of a Clinically Relevant Endpoint Requiring a Smaller Sample Size 151
30 cases of "two stage hepatectomy” for liver metastases from colorectal cancer: a single centre experience 151
[Impact of preoperative locoregional chemotherapy with fluorodeoxyuridine on the outcome of liver resection]. FT Impatto della chemioterapia locoregionale preoperatoria con fluorodesossiuridina (FUDR) sulla chirurgia resettiva epatica 151
[Advanced age as risk factor in liver resection surgery]. FT L'eta avanzata come fattore di rischio nella chirurgia resettiva epatica 150
[Is the surgical treatment of spontaneous bacterial peritonitis still up-to-date?]. FT Trattare chirurgicamente la peritonite batterica spontanea e ancora attuale? 150
[Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases]. FT Fattori prognostici dell'outcome a lungo termine della chirurgia resettiva epatica per metastasi da carcinoma colorettale 150
Liver Histology Predicts Liver Regeneration and Outcome in ALPPS: Novel Findings From A Multicenter Study 147
[Role of totally implantable systems for long-term vascular access in the treatment of the neoplastic patient]. FT Ruolo dei sistemi totalmente impiantabili per accesso vascolare a lungo termine nel trattamento del paziente neoplastico 143
Proposed modification of the eighth edition of the AJCC staging system for intrahepatic cholangiocarcinoma 141
[Multimodal approach to rectal carcinoma with hepatic metastasis]. FT Approccio multimodale al carcinoma del retto con metastasi epatica 137
A “cui prodest” evaluation on the development of a minimally invasive liver surgery program: a differential benefit analysis of open and laparoscopic approach for left and right hemihepatectomies 135
Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumab 132
[Hepatic resection of metastasis of colorectal carcinoma: analysis of long-term prognostic factors of outcome]. FT Resezioni epatiche per metastasi da carcinoma colorettale: analisi dei fattori prognostici di outcome a lungo termine 130
A Prognostic Model To Predict Survival After Recurrence Among Patients With Recurrent Hepatocellular Carcinoma 125
Liver Resection vs Nonsurgical Treatments for Patients With Early Multinodular Hepatocellular Carcinoma 123
Single-Center Retrospective Study Comparing Double Vein Embolization via a Trans-Jugular Approach with Liver Venous Deprivation via a Trans-Hepatic Approach 120
Comparing Liver Venous Deprivation and Portal Vein Embolization for Perihilar Cholangiocarcinoma: Is It Time to Shift the Focus to Hepatic Functional Reserve Rather than Hypertrophy? 120
Preoperative MRI radiomic analysis for predicting local tumor progression in colorectal liver metastases before microwave ablation 119
Role of the prognostic nutritional index in predicting survival in advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab 119
Laparoscopic versus open liver resection for large (≥ 5 cm) hepatocellular carcinoma in elderly patients: a multicenter propensity score-matched study 119
Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study 117
Clinical Outcomes After Progression on First-Line Therapies in IDH1 Mutated Versus Wild-Type Intrahepatic Cholangiocarcinoma Patients 117
Microwave ablation of liver malignancies: comparison of effects and early outcomes of percutaneous and intraoperative approaches with different liver conditions 117
Evaluation of the ACS NSQIP Surgical Risk Calculator in Elderly Patients Undergoing Hepatectomy for Hepatocellular Carcinoma 117
Adverse events as potential predictive factors of activity in patients with advanced hepatocellular carcinoma treated with lenvatinib 117
Combined hepatocellular-cholangiocarcinoma: morpho-molecular updates and considerations 117
Atezolizumab plus bevacizumab versus Lenvatinib for patients with Barcelona clinic liver cancer stage B (BCLC-B) hepatocellular carcinoma (HCC): A real-world population 116
Minimally invasive approach for liver resections in patients with hepatocellular carcinoma and Child-Pugh B cirrhosis: shifting the paradigm? Long-term Outcomes from an International Multicentre Study 115
Predicting futility of upfront surgery in perihilar cholangiocarcinoma: Machine learning analytics model to optimize treatment allocation 115
The failure to rescue factor: aftermath analyses on 224 cases of perihilar cholangiocarcinoma 113
Combined Loco-Regional and Systemic Treatment Strategies for Hepatocellular Carcinoma: From Basics to New Developments 113
Comparison between percutaneous and laparoscopic microwave ablation of hepatocellular carcinoma 113
An attempt to establish and apply global benchmarks for liver resection of malignant hepatic tumors 112
Analyzing the interaction between time to surgery and tumor burden score in hepatocellular carcinoma 112
Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population 111
Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study 111
Real-World Data on Ivosidenib in Patients with Previously Treated Isocitrate Dehydrogenase 1-Mutated Intrahepatic Cholangiocarcinomas: An Early Exploratory Analysis 110
Germline testing and genetic counseling in biliary tract cancer: an operative proposal to improve the state of art 109
Thermal ablation versus surgical resection of small-size colorectal liver metastases (COLLISION): an international, randomised, controlled, phase 3 non-inferiority trial 109
Combining Laparoscopic Liver Partitioning and Simultaneous Portohepatic Venous Deprivation for Rapid Liver Hypertrophy 108
HER2 Pathway in Biliary Tract Cancer: A Snapshot of the Current Understanding and Future Directions 108
Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial 108
Indocyanine green (ICG)-guided robotic resection for liver adenoma: combined technologies for precision surgery 107
Intermediate hepatocellular carcinoma: new horizons and prospects for our patients 106
Workflow for high-dimensional flow cytometry analysis of T cells from tumor metastases 106
Harnessing CD39 for the Treatment of Colorectal Cancer and Liver Metastases by Engineered T Cells 105
Cornerstones and divergencies in the implementation and use of liver hypertrophy techniques: results from a nationwide survey for the set-up of the prospective registry 105
Application of hazard functions to investigate recurrence after curative-intent resection for hepatocellular carcinoma 105
Higher Postoperative Mortality and Inferior Survival After Right-Sided Liver Resection for Perihilar Cholangiocarcinoma: Left-Sided Resection is Preferred When Possible 105
A stepwise learning curve to define the standard for technical improvement in laparoscopic liver resections: complexity-based analysis in 1032 procedures 105
Comparison of CMV reactivation after islet-kidney, pancreas-kidney or kidney alone transplantation in diabetic patients 105
Radial and longitudinal margins in surgery of perihilar cholangiocarcinoma: When R1 definition is associated with different prognosis 104
The Impact of Postoperative Ascites on Survival After Surgery for Hepatocellular Carcinoma: a National Study 104
Perioperative and oncologic outcomes of open radical nephrectomy and inferior vena cava thrombectomy with liver mobilization and Pringle maneuver for Mayo III level tumor thrombus: single institution experience 103
Achievement of textbook outcome after hepatectomy combined with thermal ablation for colorectal liver metastases 103
Harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells 102
Benchmarks in Liver Resection for Intrahepatic Cholangiocarcinoma 101
Next-generation sequencing analysis of cholangiocarcinoma identifies distinct IDH1-mutated clusters 101
Radioembolization for Hepatocellular Carcinoma: a Comparison on Dual-phase Cone-beam CT, Contrast-enhanced CT (CECT) and 99mTc-macroaggregated albumin-SPECT/CT in predicting final distribution volumes and dosimetry of the post-embolization 90Y PET/CT 101
Factors Associated with and Impact of Open Conversion in Laparoscopic and Robotic Minor Liver Resections: An International Multicenter Study of 10,541 Patients 101
Technique, complications, and therapeutic efficacy of percutaneous transplantation of human pancreatic islet cells in type 1 diabetes: the role of US 101
Human pancreatic islets produce and secrete MCP-1/CCL2: relevance to human islet transplantation 101
Comparing practice and outcome of laparoscopic liver resection between high-volume expert centres and nationwide low-to-medium volume centres 101
Classification of Intrahepatic Cholangiocarcinoma into Perihilar Versus Peripheral Subtype 100
Navigator nurse implementation within a fast track program of liver resections: How to improve the healthcare service and perioperative results 100
Real-Life Clinical Data of Lenvatinib versus Sorafenib for Unresectable Hepatocellular Carcinoma in Italy 100
Evaluation of the economic impact of the robotic approach in major and postero-superior segment liver resections: a multicenter retrospective analysis 99
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real-world data 99
A Nomogram to Predict Long-term Survival After Resection for Intrahepatic Cholangiocarcinoma An Eastern and Western Experience 99
Performance of comprehensive complication index and clavien‐dindo complication scoring system in liver surgery for hepatocellular carcinoma 99
The multi-societal European consensus on the terminology, diagnosis and management of patients with synchronous colorectal cancer and liver metastases: an E-AHPBA consensus in partnership with ESSO, ESCP, ESGAR, and CIRSE 98
The impact of recurrence timing and tumor burden score on overall survival among patients undergoing repeat hepatectomy for colorectal liver metastases 98
Retrospective Evaluation and Significance of Neutrophil-to-Lymphocyte Ratio Prior to and 1 month Following Microwave Ablation of Hepatocellular Carcinoma 98
Assessment of Textbook Outcome in Laparoscopic and Open Liver Surgery 98
Robotic Major Hepatectomy in Elderly Patient 98
Predictors and Prognostic Significance of Postoperative Complications for Patients with Intrahepatic Cholangiocarcinoma 97
Impact of Tumor Size on the Difficulty of Laparoscopic Major Hepatectomies: An International Multicenter Study 97
Impact of Liver Cirrhosis, Severity of Cirrhosis, and Portal Hypertension on the Difficulty and Outcomes of Laparoscopic and Robotic Major Liver Resections for Primary Liver Malignancies 97
Laparoscopic versus open resection for hepatocellular carcinoma according to the procedure's complexity: real-world weighted data from a national register 97
Correction to: Changes in surgicaL behaviOrs dUring the CoviD-19 pandemic. The SICE CLOUD19 Study (Updates in Surgery, (2021), 73, 2, (731-744), 10.1007/s13304-021-01010-w) 97
Impact of liver cirrhosis, severity of cirrhosis and portal hypertension on the difficulty of laparoscopic and robotic minor liver resections for primary liver malignancies in the anterolateral segments 97
Complications after percutaneous transaxillary implantation of a catheter for intraarterial chemotherapy of liver tumors: clinical relevance and management in 204 patients 96
Totale 13.652
Salva come PNG Salva come JPEG
Categoria #
all - tutte 372.714
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 372.714
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022402 1 0 1 153 18 40 59 52 29 15 9 25
2022/20233.701 1.842 578 182 28 50 342 314 199 105 23 23 15
2023/20241.498 39 31 119 95 96 177 55 111 7 95 167 506
2024/202512.456 1.613 325 142 155 267 986 1.642 1.081 2.370 1.904 875 1.096
2025/202642.383 2.611 3.697 4.689 6.017 2.787 1.098 3.288 2.724 10.072 2.380 1.416 1.604
2026/20271.378 1.378 0 0 0 0 0 0 0 0 0 0 0
Totale 62.505